Physician profile
A Michael Coppa
NPI 1114964251
$3,142.36
in general payments reported to CMS, 2019-2025
15 companies · $21.25 in 2025
The $21.25 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $108 · 2021: $133 · 2022: $182 · 2023: $2,053 · 2024: $540 · 2025: $21.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $113.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,577.21 | 2020-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.03 | 2019-2022 | |
| Agile Therapeutics, INC. | $80.91 | 2021-2022 | |
| Evofem Biosciences, INC. | $69.10 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $52.74 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $51.15 | 2020-2021 | |
| Daiichi Sankyo INC. | $42.65 | 2020-2021 | |
| Myovant Sciences INC. | $32.43 | 2021-2022 | |
| Allergan, INC. | $31.72 | 2019 | |
| Avion Pharmaceuticals | $26.49 | 2019-2020 | |
| Coopersurgical, INC. | $23.91 | 2024 | Paragard T 380a |
| Sage Therapeutics, LLC | $21.25 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $18.12 | 2019 | |
| Shield Therapeutics INC | $15.81 | 2024 | |
| Exeltis, USA INC. | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw A Michael Coppa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.